Clinical Trials Browser

Phase 1/2 × INDUSTRY × Standard of Care × Clear all

NCT07206056 2026-03-02

TulmiSTAR-01

Phase 1/2 Recruiting

Progressive Metastatic Castrate Resistant Prostate Cancer

NCT05405595 2026-01-07

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced/Metastatic Solid Tumors